June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Mass Spectrometric Proteomic Analysis of Human Glaucomatous Retinae
Author Affiliations & Notes
  • Sebastian Funke
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Natarajan Perumal
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Sabine Beck
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Silke Gabel-Scheurich
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Carsten Schmelter
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Claudia Gerbig
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Oliver Gramlich
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
  • Norbert Pfeiffer
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Franz H Grus
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Footnotes
    Commercial Relationships Sebastian Funke, None; Natarajan Perumal, None; Sabine Beck, None; Silke Gabel-Scheurich, None; Carsten Schmelter, None; Claudia Gerbig, None; Oliver Gramlich, None; Norbert Pfeiffer, None; Franz Grus, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3658. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sebastian Funke, Natarajan Perumal, Sabine Beck, Silke Gabel-Scheurich, Carsten Schmelter, Claudia Gerbig, Oliver Gramlich, Norbert Pfeiffer, Franz H Grus; Mass Spectrometric Proteomic Analysis of Human Glaucomatous Retinae. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3658.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Proteomic changes have been observed due to neurodegenerative processes in ocular sample species, in cell and animal models. Investigations on human retina samples are still rare. Therefore, we analyzed retina samples of glaucoma and non-glaucoma control donors by mass spectrometry (MS) to uncover glaucoma associated proteomic changes and to provide new molecular candidates contributing to a better understanding of glaucoma.

Methods: Retina extracts of glaucoma donors (N=5) and non-glaucoma donors (N=5) have been analyzed using a bottom-up high performance liquid chromatography electro spray ionization MS (BU HPLC ESI MS) workflow followed by label-free quantification and functional analysis. Candidate protein validation has been realized in pooled samples using targeted label-free quantification. Candidates have been verified in the retinal ganglion cell layer (GCL) by laser capture microdissection (LCM).

Results: BU HPLC ESI MS of human retina samples resulted in the identification of >600 proteins (FDR<1%). 10% of proteins showed distinct alterations related to glaucoma. Among these proteins, especially mitochondrial and nucleus species, displayed significant or distinct glaucoma associated level alterations (p<0.05, p<0.1). Abundance changes of key process participants of cell death or cell development could be recorded. Beyond increase of stress related proteins, also decrease of new glaucoma related candidates encircling GCL supported ADP/ATP translocase 3 (ANT3) and methyl-CpG-binding protein 2 (MeCp2) could be documented.

Conclusions: A sensitive view to the human retina proteome could be achieved. Moreover, distinct proteomic changes affecting key cellular processes could be revealed in human glaucoma retinae recommending new candidate proteins, e.g. ANT3 and MeCp2.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×